Feature Article Respiratory medicine Drug-induced interstitial lung disease – a heterogeneous old foe with an evolving new face Senthuran Shivakumar, Yet Hong Khor RespiratoryMedicineToday September 2023 2023; 8(2): 14-19
Regular Series Perspectives Oral corticosteroid stewardship in asthma: an urgent issue John Politis, Philip Bardin, John Blakey RespiratoryMedicineToday September 2022 2022; 7(2): 26-29
Feature Article Respiratory medicine Inhaler therapy for asthma Debbie Rigby RespiratoryMedicineToday April 2022 2022; 7(1): 14-19
Clinical Flowchart Respiratory medicine An approach to inhaler device selection Debbie Rigby RespiratoryMedicineToday September 2021 2021; 6(2): 13-17
Feature Article Respiratory medicine Inhaler therapy for COPD: an individualised approach to inhaler selection Debbie Rigby RespiratoryMedicineToday September 2021 2021; 6(2): 13-17
Regular Series Case review Aspirin-exacerbated respiratory disease. More than just sensitivity to aspirin Emma L. Gray, Helen K. Reddel RespiratoryMedicineToday June 2019 2019; 4(2): 35-40
Clinical Flowchart Respiratory medicine 2. Pharmacotherapy considerations for patients with COPD already established on an ICS-containing medication regimen Peter A Frith, Ian A. Yang, Kerry Hancock RespiratoryMedicineToday October 2018 2018; 3(2): 35-40
Clinical Flowchart Respiratory medicine 1. Suggested initial pharmacotherapy for COPD Peter A Frith, Ian A. Yang, Kerry Hancock RespiratoryMedicineToday October 2018 2018; 3(2): 35-40
Regular Series Perspectives Inhaled corticosteroids in COPD: when are they needed, when not needed and when harmful? Peter A. Frith, Ian A. Yang, Kerry Hancock RespiratoryMedicineToday October 2018 2018; 3(2): 35-40
Regular Series Therapeutics clinic Severe refractory asthma. The promise of new treatments Constance H. Katelaris RespiratoryMedicineToday June 2018 2018; 3(1): 21-24
Feature Article Respiratory medicine What’s new in asthma treatment? John W Upham, Lauren M Galt RespiratoryMedicineToday October 2016 2016; 1(1): 26-29